BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia
BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia is a paper indexed in PICO Portal from OpenAlex.
How many citations does BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia have?
BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia has 225 citations in the OpenAlex counts PICO Portal stores.
When was BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia published?
BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia has 2002 year in the PICO Portal index.
What is the open-access status of BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia?
BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia has closed oa status in the PICO Portal index.
What is the DOI of BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia?
The DOI for BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia is on the source record.
What is the PMID of BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia?
The PMID for BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia is on the source record.
What is the OpenAlex record for BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia?
The OpenAlex for BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia is on the source record.